Carl N. Skold
- Molecular Biology
- Biomedical Engineering
- Radiology, Nuclear Medicine and Imaging
- Organic Chemistry
- Materials Chemistry
- Co-authors
- Edwin F. UllmanArthur C. SwitchenkoSharat SinghBenjamin R. IrvinAlan DaffornR. H. SchlessingerZai‐Sheng WuMarcel R. Pirio
- Topics
- Monoclonal and Polyclonal Antibodies Research (5 papers)Advanced Biosensing Techniques and Applications (3 papers)Glycosylation and Glycoproteins Research (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyThe Journal of Immunology
- Partner nations
- United States
In The Last Decade
Carl N. Skold
11 papers receiving 580 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 374
- Biomedical Engineering 118
- Radiology, Nuclear Medicine and Imaging 106
- Organic Chemistry 73
- Materials Chemistry 59
Countries citing papers authored by Carl N. Skold
This map shows the geographic impact of Carl N. Skold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl N. Skold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl N. Skold more than expected).
Fields of papers citing papers by Carl N. Skold
This network shows the impact of papers produced by Carl N. Skold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl N. Skold. The network helps show where Carl N. Skold may publish in the future.
Co-authorship network of co-authors of Carl N. Skold
This figure shows the co-authorship network connecting the top 25 collaborators of Carl N. Skold. A scholar is included among the top collaborators of Carl N. Skold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl N. Skold. Carl N. Skold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 202 | |
| 2 | 261 | |
| 3 | 39 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | Enzyme-enhancement immunoassay: a homogeneous assay for polyvalent ligands and antibodies. | 6 |
| 8 | 35 | |
| 9 | 16 | |
| 10 | 2 | |
| 11 | 51 |
About Carl N. Skold
Carl N. Skold is a scholar working on Biotechnology, Radiology, Nuclear Medicine and Imaging and Physical and Theoretical Chemistry, having authored 11 papers that have together received 623 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Advanced Biosensing Techniques and Applications (3 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Molecular Biology (374 citations), Radiology, Nuclear Medicine and Imaging (106 citations) and Virology (14 citations). Carl N. Skold has collaborated with scholars based in United States. Frequent co-authors include Edwin F. Ullman, Arthur C. Switchenko, Sharat Singh, Benjamin R. Irvin, Alan Dafforn, R. H. Schlessinger, Zai‐Sheng Wu, Marcel R. Pirio, Rajesh Patel and Dariush Davalian. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.